364 related articles for article (PubMed ID: 32189305)
1. Sickle Cell Hemoglobin.
Mandal AK; Mitra A; Das R
Subcell Biochem; 2020; 94():297-322. PubMed ID: 32189305
[TBL] [Abstract][Full Text] [Related]
2. Molecular insights of inhibition in sickle hemoglobin polymerization upon glutathionylation: hydrogen/deuterium exchange mass spectrometry and molecular dynamics simulation-based approach.
Das R; Mitra A; Mitra G; Maity D; Bhat V; Pal D; Ross C; Kurpad AV; Mandal AK
Biochem J; 2018 Jul; 475(13):2153-2166. PubMed ID: 29858275
[TBL] [Abstract][Full Text] [Related]
3. Application of isotope exchange based mass spectrometry to understand the mechanism of inhibition of sickle hemoglobin polymerization upon oxygenation.
Das R; Mitra A; Bhat V; Mandal AK
J Struct Biol; 2017 Jul; 199(1):76-83. PubMed ID: 28465180
[TBL] [Abstract][Full Text] [Related]
4. On the Nonaggregation of Normal Adult Hemoglobin and the Aggregation of Sickle Cell Hemoglobin.
Galamba N
J Phys Chem B; 2019 Dec; 123(50):10735-10745. PubMed ID: 31747289
[TBL] [Abstract][Full Text] [Related]
5. A recombinant human hemoglobin with anti-sickling properties greater than fetal hemoglobin.
Levasseur DN; Ryan TM; Reilly MP; McCune SL; Asakura T; Townes TM
J Biol Chem; 2004 Jun; 279(26):27518-24. PubMed ID: 15084588
[TBL] [Abstract][Full Text] [Related]
6. Modeling sickle hemoglobin fibers as one chain of coarse-grained particles.
Li H; Ha V; Lykotrafitis G
J Biomech; 2012 Jul; 45(11):1947-51. PubMed ID: 22673758
[TBL] [Abstract][Full Text] [Related]
7. Mesoscopic Adaptive Resolution Scheme toward Understanding of Interactions between Sickle Cell Fibers.
Lu L; Li H; Bian X; Li X; Karniadakis GE
Biophys J; 2017 Jul; 113(1):48-59. PubMed ID: 28700924
[TBL] [Abstract][Full Text] [Related]
8. A Triazole Disulfide Compound Increases the Affinity of Hemoglobin for Oxygen and Reduces the Sickling of Human Sickle Cells.
Nakagawa A; Ferrari M; Schleifer G; Cooper MK; Liu C; Yu B; Berra L; Klings ES; Safo RS; Chen Q; Musayev FN; Safo MK; Abdulmalik O; Bloch DB; Zapol WM
Mol Pharm; 2018 May; 15(5):1954-1963. PubMed ID: 29634905
[TBL] [Abstract][Full Text] [Related]
9. MetAP2 inhibition modifies hemoglobin S to delay polymerization and improves blood flow in sickle cell disease.
Demers M; Sturtevant S; Guertin KR; Gupta D; Desai K; Vieira BF; Li W; Hicks A; Ismail A; Gonçalves BP; Di Caprio G; Schonbrun E; Hansen S; Musayev FN; Safo MK; Wood DK; Higgins JM; Light DR
Blood Adv; 2021 Mar; 5(5):1388-1402. PubMed ID: 33661300
[TBL] [Abstract][Full Text] [Related]
10. Systematic enhancement of polymerization of recombinant sickle hemoglobin mutants: implications for transgenic mouse model for sickle cell anemia.
Li X; Mirza UA; Chait BT; Manning JM
Blood; 1997 Dec; 90(11):4620-7. PubMed ID: 9373274
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, and Evaluation of Allosteric Effectors for Hemoglobin.
Enakaya NA; Jefferson A; Chew-Martinez D; Matthews JS
Acc Chem Res; 2023 Jun; 56(11):1279-1286. PubMed ID: 36946781
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of carbonmonoxy sickle hemoglobin in R-state conformation.
Ghatge MS; Ahmed MH; Omar AS; Pagare PP; Rosef S; Kellogg GE; Abdulmalik O; Safo MK
J Struct Biol; 2016 Jun; 194(3):446-50. PubMed ID: 27085422
[TBL] [Abstract][Full Text] [Related]
13. Interactions of an Anti-Sickling Drug with Hemoglobin in Red Blood Cells from a Patient with Sickle Cell Anemia.
Strader MB; Liang H; Meng F; Harper J; Ostrowski DA; Henry ER; Shet AS; Eaton WA; Thein SL; Alayash AI
Bioconjug Chem; 2019 Mar; 30(3):568-571. PubMed ID: 30794381
[TBL] [Abstract][Full Text] [Related]
14. "Sickling" in vertebrates: Animal studies vs. sickle cell disease.
Steinberg MH
Blood Rev; 2019 Jul; 36():88-94. PubMed ID: 31084943
[TBL] [Abstract][Full Text] [Related]
15. On the Binding Free Energy and Molecular Origin of Sickle Cell Hemoglobin Aggregation.
Galamba N; Pipolo S
J Phys Chem B; 2018 Aug; 122(30):7475-7483. PubMed ID: 29995412
[TBL] [Abstract][Full Text] [Related]
16. High-throughput assessment of hemoglobin polymer in single red blood cells from sickle cell patients under controlled oxygen tension.
Di Caprio G; Schonbrun E; Gonçalves BP; Valdez JM; Wood DK; Higgins JM
Proc Natl Acad Sci U S A; 2019 Dec; 116(50):25236-25242. PubMed ID: 31767751
[TBL] [Abstract][Full Text] [Related]
17. Unraveling DEHP influence on hemoglobin S polymerization in sickle cell disease: Ex vivo, in vitro and in silico analysis.
Camacho RA; Machado AV; de Oliveira Mendonça F; Teixeira-Alves LR; Guimarães-Nobre CC; Mendonça-Reis E; da Silva PF; Cardim-Pires TR; Miranda-Alves L; Berto-Junior C
Toxicol In Vitro; 2024 Jun; 98():105832. PubMed ID: 38653437
[TBL] [Abstract][Full Text] [Related]
18. Sickling of nucleated erythroid precursors from patients with sickle cell anemia.
Hasegawa S; Rodgers GP; Dwyer N; Noguchi CT; Blanchette-Mackie EJ; Uyesaka N; Schechter AN; Fibach E
Exp Hematol; 1998 Apr; 26(4):314-9. PubMed ID: 9546314
[TBL] [Abstract][Full Text] [Related]
19. PF-07059013: A Noncovalent Modulator of Hemoglobin for Treatment of Sickle Cell Disease.
Gopalsamy A; Aulabaugh AE; Barakat A; Beaumont KC; Cabral S; Canterbury DP; Casimiro-Garcia A; Chang JS; Chen MZ; Choi C; Dow RL; Fadeyi OO; Feng X; France SP; Howard RM; Janz JM; Jasti J; Jasuja R; Jones LH; King-Ahmad A; Knee KM; Kohrt JT; Limberakis C; Liras S; Martinez CA; McClure KF; Narayanan A; Narula J; Novak JJ; O'Connell TN; Parikh MD; Piotrowski DW; Plotnikova O; Robinson RP; Sahasrabudhe PV; Sharma R; Thuma BA; Vasa D; Wei L; Wenzel AZ; Withka JM; Xiao J; Yayla HG
J Med Chem; 2021 Jan; 64(1):326-342. PubMed ID: 33356244
[TBL] [Abstract][Full Text] [Related]
20. Targeting βCys93 in hemoglobin S with an antisickling agent possessing dual allosteric and antioxidant effects.
Kassa T; Strader MB; Nakagawa A; Zapol WM; Alayash AI
Metallomics; 2017 Sep; 9(9):1260-1270. PubMed ID: 28770911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
